Clinical Trials
73 trialsPembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Emory University
PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
University of Wisconsin, Madison
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
KZR-261 in Subjects With Advanced Solid Malignancies
Kezar Life Sciences, Inc.
AMPLIFY-201
Elicio Therapeutics
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Incyte Corporation
CNSI-Fe(II)
Sichuan Enray Pharmaceutical Sciences Company
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Trishula Therapeutics, Inc.
MasterKey-01
Black Diamond Therapeutics, Inc.
A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery
Boehringer Ingelheim
V941-001
Merck Sharp & Dohme LLC
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
Pfizer
MK-8353-013
Merck Sharp & Dohme LLC
KEYNOTE-651
Merck Sharp & Dohme LLC
ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
MEI Pharma, Inc.
A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma
Pfizer
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery
Wake Forest University Health Sciences
Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery
M.D. Anderson Cancer Center
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
Pfizer
Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors
Pfizer
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
DC Vaccine in Colorectal Cancer
University of Pennsylvania
Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Amgen
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Pfizer
CITRINO
Tesaro, Inc.
Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC
Morphotek
Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101
Eisai Inc.
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Pfizer
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Pfizer
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Ipsen
To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
Abramson Cancer Center at Penn Medicine
Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer
Ludwig Institute for Cancer Research
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
Herlev Hospital
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
Karyopharm Therapeutics Inc
Pilot Study of GVAX in Colorectal Cancer Cells
Massachusetts General Hospital
A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
Ludwig Institute for Cancer Research
A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab
Ludwig Institute for Cancer Research
Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
Ludwig Institute for Cancer Research
Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer
Ludwig Institute for Cancer Research
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
OBI Pharma, Inc
PICCASSO
University Hospital Heidelberg
Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer
SCRI Development Innovations, LLC
SENTINEL
GSO Global Clinical Research BV
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
EMD Serono
Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening
Roswell Park Cancer Institute
MErCuRIC1
University of Oxford
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers
National Cancer Institute (NCI)
MK-1697-001
Merck Sharp & Dohme LLC
A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer
Otsuka Pharmaceutical Co., Ltd.
An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Navidea Biopharmaceuticals